PL1667668T3 - Antagoniści integryny alfavbeta3 oraz alfavbeta6 jako czynniki przeciwzwłóknieniowe - Google Patents

Antagoniści integryny alfavbeta3 oraz alfavbeta6 jako czynniki przeciwzwłóknieniowe

Info

Publication number
PL1667668T3
PL1667668T3 PL04765296T PL04765296T PL1667668T3 PL 1667668 T3 PL1667668 T3 PL 1667668T3 PL 04765296 T PL04765296 T PL 04765296T PL 04765296 T PL04765296 T PL 04765296T PL 1667668 T3 PL1667668 T3 PL 1667668T3
Authority
PL
Poland
Prior art keywords
alfavbeta6
alfavbeta3
integrin antagonists
antifibrotic agents
antifibrotic
Prior art date
Application number
PL04765296T
Other languages
English (en)
Inventor
Simon Goodman
Detlef Schuppan
Eleonora Patsenker
Yury Popov
Michael Bauer
Matthias Wiesner
Alfred Jonczyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL1667668T3 publication Critical patent/PL1667668T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL04765296T 2003-10-01 2004-09-16 Antagoniści integryny alfavbeta3 oraz alfavbeta6 jako czynniki przeciwzwłóknieniowe PL1667668T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03022048 2003-10-01
EP04765296A EP1667668B1 (en) 2003-10-01 2004-09-16 Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
PCT/EP2004/010396 WO2005039547A1 (en) 2003-10-01 2004-09-16 Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents

Publications (1)

Publication Number Publication Date
PL1667668T3 true PL1667668T3 (pl) 2008-10-31

Family

ID=34486055

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04765296T PL1667668T3 (pl) 2003-10-01 2004-09-16 Antagoniści integryny alfavbeta3 oraz alfavbeta6 jako czynniki przeciwzwłóknieniowe

Country Status (18)

Country Link
US (1) US20070117849A1 (pl)
EP (1) EP1667668B1 (pl)
JP (1) JP4912881B2 (pl)
KR (1) KR101191068B1 (pl)
CN (1) CN100462068C (pl)
AR (1) AR045960A1 (pl)
AT (1) ATE399542T1 (pl)
AU (1) AU2004283413B2 (pl)
BR (1) BRPI0414927A (pl)
CA (1) CA2540730C (pl)
DE (1) DE602004014795D1 (pl)
DK (1) DK1667668T3 (pl)
ES (1) ES2308227T3 (pl)
MX (1) MXPA06003477A (pl)
PL (1) PL1667668T3 (pl)
RU (1) RU2388472C2 (pl)
WO (1) WO2005039547A1 (pl)
ZA (1) ZA200603427B (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147019A (en) 2002-03-13 2012-10-15 Biogen Idec Inc Anti-alpha v beta 6 antibodies
GB0722650D0 (en) * 2007-11-19 2007-12-27 Ge Healthcare Ltd Novel imaging method
CN101497656B (zh) * 2009-03-09 2012-08-15 东南大学 与整合素αvβ3具有高结合活性的多肽及其应用
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
US20150086570A1 (en) * 2012-03-29 2015-03-26 Biogen Idec Ma Inc. Biomarkers for use in integrin therapy applications
IN2015DN00099A (pl) 2012-07-18 2015-05-29 Univ Saint Louis
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
EP3266782B1 (en) 2013-02-07 2019-10-30 SciFluor Life Sciences, Inc. Fluorinated integrin antagonists
US10035859B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
WO2014143739A2 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof
EP3925959A1 (en) 2015-02-19 2021-12-22 OcuTerra Therapeutics, Inc. Fluorinated derivatives of 3-(2-oxo-3-(3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl)imidazolidin-1-yl)propanoic acid and uses thereof
HK1244806A1 (zh) 2015-12-30 2018-08-17 Saint Louis University 作為過氧乙醯硝酸整聯蛋白拮抗劑的間氮雜環氨基苯甲酸衍生物
AU2017359028A1 (en) * 2016-11-08 2019-06-20 Bristol-Myers Squibb Company Azole amides and amines as alpha V integrin inhibitors
EP3538528B1 (en) * 2016-11-08 2020-12-23 Bristol-Myers Squibb Company Pyrrole amides as alpha v integrin inhibitors
CA3045944A1 (en) 2016-12-07 2018-06-14 Progenity, Inc. Gastrointestinal tract detection methods, devices and systems
CN116712540A (zh) 2016-12-14 2023-09-08 比奥拉治疗股份有限公司 使用整联蛋白抑制剂治疗胃肠道疾病
EP3810085A1 (en) 2018-06-20 2021-04-28 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
CN113348011B (zh) 2018-11-19 2023-04-18 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
CN120960406A (zh) * 2024-05-16 2025-11-18 浙江大学 靶向整合素αVβ6的CAR-免疫细胞在预防和/或治疗纤维化疾病中的应用
CN118641765B (zh) * 2024-05-17 2025-06-20 中国医学科学院医药生物技术研究所 Tinagl1在制备抗肝纤维化药物中的应用及化合物的新用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW352384B (en) * 1992-03-24 1999-02-11 Hoechst Ag Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
CA2371824A1 (en) * 1999-02-20 2000-08-24 Merck Patent Gesellschaft Mit Beschraenkter Haftung .beta.-alanine derivatives
DE19933173A1 (de) * 1999-07-15 2001-01-18 Merck Patent Gmbh Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶
DE10006139A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Indol-3-yl-Derivate
DE10063173A1 (de) * 2000-12-18 2002-06-20 Merck Patent Gmbh Harnstoff- und Urethanderivate
NZ528076A (en) 2001-03-02 2005-09-30 Medimmune Inc Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules
DE10112771A1 (de) * 2001-03-16 2002-09-26 Merck Patent Gmbh Inhibitoren des Integrins alpha¶v¶beta¶6¶
AU2002319282B2 (en) * 2001-08-01 2007-06-28 Merck Patent Gmbh Integrin inhibitors for the treatment of eye diseases
CN1658894A (zh) * 2002-02-14 2005-08-24 默克专利股份有限公司 用于治疗眼病的方法和组合物

Also Published As

Publication number Publication date
AR045960A1 (es) 2005-11-16
KR20060090818A (ko) 2006-08-16
JP4912881B2 (ja) 2012-04-11
BRPI0414927A (pt) 2006-11-07
RU2388472C2 (ru) 2010-05-10
CN100462068C (zh) 2009-02-18
AU2004283413A1 (en) 2005-05-06
ZA200603427B (en) 2007-09-26
JP2007507440A (ja) 2007-03-29
AU2004283413B2 (en) 2010-09-02
ES2308227T3 (es) 2008-12-01
EP1667668B1 (en) 2008-07-02
CA2540730C (en) 2012-08-21
ATE399542T1 (de) 2008-07-15
RU2006114395A (ru) 2007-11-27
WO2005039547A1 (en) 2005-05-06
CN1863520A (zh) 2006-11-15
CA2540730A1 (en) 2005-05-06
EP1667668A1 (en) 2006-06-14
DE602004014795D1 (de) 2008-08-14
MXPA06003477A (es) 2006-06-05
US20070117849A1 (en) 2007-05-24
KR101191068B1 (ko) 2012-10-15
DK1667668T3 (da) 2008-09-15

Similar Documents

Publication Publication Date Title
AU2003265853A8 (en) Hedgehog antagonists, methods and uses related thereto
EP1541585A4 (en) CXCR4 ANTAGONIST AND USE THEREOF
DK1667668T3 (da) Alfabeta3 og altabeta6-integrinantagonister som antifibrotiske midler
PL1641787T3 (pl) Podstawione diketopiperazyny i ich zastosowanie jako antagonistów oksytocyny
EP1562593A4 (en) Topoisomerase-targeting agents
GB2418661B (en) Construction machine and projecting member thereof`
GB0318546D0 (en) Quinoxalinones and their use
GB0300805D0 (en) Compounds and their use
GB0300804D0 (en) Compounds and their use
PT1667668E (pt) Antagonistas de integrinas alfavbeta3 e alfavbeta6 como agentes antifibróticos
GB0710292D0 (en) Cosmetic agents and methods for the preparation thereof
TWI320409B (en) Urea derivatives as integrin 4 antagonists
SI1641787T1 (sl) Substituirani diketopiperazini in njihova uporabakot oksitocinski antagonisti
GB0317133D0 (en) Compounds and their use
IL163932A0 (en) Polyethers and their use as carrieoils
GB0320064D0 (en) Compounds and their use
GB0316113D0 (en) Compounds and their use
GB0310471D0 (en) Compounds and their use
GB0310472D0 (en) Compounds and their use
GB0320062D0 (en) Compounds and their use
GB0314291D0 (en) Compounds and their use
GB0304820D0 (en) Compounds and their use
GB0314292D0 (en) Compounds and their use
GB0301147D0 (en) Compounds and their use
GB0309319D0 (en) Compounds and their use